Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis.
about
Development of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future ApplicationsAntipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapyThe impact of antipsychotic polytherapy costs in the public health care in Sao Paulo, BrazilValidation of a claims-based antipsychotic polypharmacy measureEffect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study.Safety and tolerability of antipsychotic polypharmacy.Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practiceAntipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysisAntipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness.Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.Prospective association between late-life physical activity and hospital care utilisation: a 7-year nationwide follow-up study.Polypharmacy and comorbidity are associated with a lower early virologic response in hepatitis C patients treated with first generation protease inhibitor triple therapy: a preliminary analysis.Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.Antipsychotic polypharmacy prescribing and risk of hospital readmission.
P2860
Q28552825-6176CA99-534C-414F-A2E8-9176F067BABEQ34686544-BED9A781-BE27-4945-8CAB-A5943545599DQ35324015-8A1F089F-3AC3-4196-AED5-8750E7B3E733Q35801221-E712F129-2BF5-4130-A9DC-970D07DE81D3Q36000102-C03ACF6A-7948-4ECA-924B-84530A851B2BQ36062421-5DAE5C4B-7A2C-4BDA-AE08-08735EA33393Q37029622-2C82CF5B-DB87-4813-BF26-8B6C8B590EF1Q37216848-661F78B2-9A56-4CC8-8632-EB50D4FC259FQ37609168-FE5BDB76-A1AE-48C7-B436-302D7C003164Q38081872-642B51AC-C24A-458F-914C-0F1D681474E0Q38769838-158876B4-A5D5-42EF-A53E-5A5AE9F04BD4Q39182650-A8355AA0-CD8A-428F-B5AB-77368480CD47Q42278251-2D04312F-2684-4E79-9781-F685B2F8352AQ47152270-E5BF9356-1B7B-4DDD-B606-80D00112E69DQ47586829-6CF4256C-6322-4D91-867A-784143D0820F
P2860
Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Association of antipsychotic p ...... register-based cost analysis.
@en
Association of antipsychotic p ...... register-based cost analysis.
@nl
type
label
Association of antipsychotic p ...... register-based cost analysis.
@en
Association of antipsychotic p ...... register-based cost analysis.
@nl
prefLabel
Association of antipsychotic p ...... register-based cost analysis.
@en
Association of antipsychotic p ...... register-based cost analysis.
@nl
P2093
P2860
P50
P1476
Association of antipsychotic p ...... register-based cost analysis.
@en
P2093
Henrik Lublin
Jan Sørensen
Lone Baandrup
P2860
P2888
P304
P356
10.1007/S10198-011-0308-0
P577
2011-03-31T00:00:00Z